Hexcel Q2 sales rise on commercial aerospace demand
Reuters2026/07/29 20:37
Overview
U.S. composites maker's Q2 sales rose 8%, a slight beat versus analyst expectations
Adjusted EPS for Q2 was $0.66, beating analyst expectations
Company raised 2026 sales and adjusted EPS guidance on strong commercial aerospace demand
Outlook
Hexcel raises FY 2026 sales guidance to $2.025 bln-$2.125 bln from $2.0 bln-$2.1 bln
Company increases FY 2026 adjusted EPS guidance to $2.30-$2.40 from $2.10-$2.30
Hexcel maintains FY 2026 free cash flow guidance above $195 mln and capex below $100 mln
Result Drivers
COMMERCIAL AEROSPACE DEMAND - Co said rising build rates at commercial aerospace customers, especially Airbus A350 and Boeing 787, drove strong sales growth
OPERATING LEVERAGE - Higher sales volumes generated operating leverage, contributing to improved gross margin and earnings
DEFENSE, SPACE OTHER DECLINE - Sales in defense, space and other markets fell due to the divestment of the Austrian-based industrial business
Company press release: ID:nBw13mxfza
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 Sales |
Slight Beat* |
$529.30 mln |
$527.91 mln (13 Analysts) |
Q2 Adjusted EPS |
Beat |
$0.66 |
$0.58 (14 Analysts) |
Q2 EPS |
|
$0.64 |
|
Q2 Adjusted operating income |
Beat |
$73.60 mln |
$69.10 mln (12 Analysts) |
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy", 12 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the aerospace defense peer group is "buy."
Wall Street's median 12-month price target for Hexcel Corp is $97.00, about 11.8% below its July 28 closing price of $110.03
The stock recently traded at 40 times the next 12-month earnings vs. a P/E of 33 three months ago
Reuters Recommended Reads
July 29 - Airbus upbeat on deliveries after strong Q2, softens tone in engine dispute
July 28 - Boeing misses Q2 core loss per share estimates as VC-25B charges weigh
July 28 - France's MEMSCAP Q2 revenue rises on aerospace and medical strength
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES <UCFIW.O> REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES <OST.O> REASON NOT AVAILABLE AT 03:28 AM